Iconix Inks Biomarker Research Deal with Brigham and Women s Hospital Researcher | GenomeWeb

NEW YORK, Sept. 20 (GenomeWeb News) - Iconix Pharmaceuticals said today that it has signed an agreement to work with Roderick Jensen, acting director of the biotechnology center and laboratory for functional genomics at the Brigham and Women's Hospital, on the study and validation of gene expression patterns in patients with neurological diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.